OKYO Pharma Limited (NASDAQ: OKYO), an ophthalmology-focused bio-pharmaceutical company which is developing urcosimod ...

Recent reorganizations and "reductions in force" at the FDA have damaged the very backbone of our public health system.

Key Takeaways Gabapentinoids do not appear to increase risk of self-harmResearchers found that people prescribed the drugs ...